Amicogen, Inc. (KOSDAQ:092040)
South Korea · Delayed Price · Currency is KRW 1,650.00
+25.00 (1.54%)
Apr 1, 2026, 3:30 PM KST
Amicogen Market Cap
Amicogen has a market cap or net worth of 116.25 billion as of April 1, 2026. Its market cap has decreased by -42.68% in one year.
Market Cap
116.25B
Enterprise Value
215.49B
Revenue
87.97B
Ranking
n/a
PE Ratio
n/a
Stock Price
1,650.00
Market Cap Chart
Since September 12, 2013, Amicogen's market cap has decreased from 237.19B to 116.25B, a decrease of -50.99%. That is a compound annual growth rate of -5.52%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 31, 2026 | 114.49B | 15.70% |
| Dec 30, 2025 | 98.95B | -53.23% |
| Dec 30, 2024 | 211.59B | -48.65% |
| Dec 28, 2023 | 412.06B | 8.63% |
| Dec 29, 2022 | 379.32B | -38.89% |
| Dec 30, 2021 | 620.70B | -14.98% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Genexine | 221.71B |
| MedPacto | 195.37B |
| Vaxcell-Bio Therapeutics | 181.64B |
| Macrogen | 174.76B |
| ENCell | 168.74B |
| iNtRON Biotechnology | 127.22B |
| CG Invites | 125.88B |
| IMB Dx | 92.66B |